Our patient support offerings and DTx safeguard outcomes for our partners and their patients. Building on our award-winning MyTherapy platform, we deliver outstanding engagement, scalability, and time-to-market.
Partners from life science and health care benefit from improved medication adherence and persistence, a higher share of voice, aggregate real-world patient insight and a compliant environment for operating DTx.
We combine our proven technical platform with years of know-how on patient engagement, regulatory requirements, and analytics. Together with our partners, we apply these for co-creating uniquely engaging support offerings and effective DTx that are tailored to both the needs of their patients, and of their brand team.
Millions of patients use our app to take their medication safely and responsibly. For our partners, we build on top of this outstanding engagement. Using MyTherapy, we implement fully tailored care pathways across app, web, and call-center channels. Because medication adherence and persistence are about much more than reminders.
Channel preferences not only differ from patient to patient, but also along the care pathway. While an app, for example, is very suitable for managing day-to-day treatment, a nurse may be far more effective during enrollment. Our platform connects app, web, and call-center CRM systems into effective multichannel pathways. The result? Fewer dropouts during enrollment and exceptional retention and persistence.
University hospitals, such as Charité Berlin, tested our platform with geriatric patients and patients with renal transplants. They found that using our app translates into better adherence and subjective well-being. Our industry partners benefit from this proven effectiveness and can leverage it further. While we never share individual users’ data, we can provide unique aggregate real-world insight for understanding medication adherence within specific groups of patients.